ACAD
27.32
-0.47
-1.69%
AEMD
4.64
-0.03
-0.64%
APRI
1.32
+0.03
+2.33%
ARNA
1.43
-0.02
-1.38%
ATEC
4.99
-0.09
-1.77%
CNAT
1.93
+0.05
+2.6543%
CRXM
0.16
-0.01
-5.83%
CYTX
1.55
-0.01
-0.64%
DXCM
65
+0.55
+0.85%
GNMK
11.02
-0.32
-2.82%
HALO
11.445
-0.375
-3.173%
ILMN
126.18
-1.74
-1.36%
INNV
0.261
+0.003
+1.15892%
INO
7.06
-0.02
-0.28%
ISCO
1.2
+0.05
+4.35%
ISIS
0
0.00
0.00%
LGND
105.24
-1.27
-1.19%
LPTN
2.67
-0.046
-1.6972%
MBVX
4.07
-0.05
-1.21%
MEIP
1.55
-0.05
-3.13%
MNOV
7.64
+0.43
+5.96%
MRTX
5.075
-0.075
-1.456%
MSTX
0.083
-0.001
-0.9512%
NBIX
43.64
+0.03
+0.07%
NUVA
65.98
+0.12
+0.18%
ONCS
1.31
-0.05
-3.68%
ONVO
3.034
-0.066
-2.1419%
OREX
1.86
-0.04
-2.11%
OTIC
15.5
+0.35
+2.31%
QDEL
22.01
-0.01
-0.05%
RCPT
0
0.00
0.00%
RGLS
2.575
-0.275
-9.649%
RMD
59.06
-0.87
-1.45%
SCIE
0.002
+0.001
+35.7143%
SPHS
2.74
-0.06
-2.14%
SRNE
5.25
-0.05
-0.94%
TROV
2.45
-0.05
-2.00%
VICL
2.31
+0.01
+0.43%
ZGNX
13.1
+0.4
+3.15%
ACAD
27.32
-0.47
-1.69%
AEMD
4.64
-0.03
-0.64%
APRI
1.32
+0.03
+2.33%
ARNA
1.43
-0.02
-1.38%
ATEC
4.99
-0.09
-1.77%
CNAT
1.93
+0.05
+2.6543%
CRXM
0.16
-0.01
-5.83%
CYTX
1.55
-0.01
-0.64%
DXCM
65
+0.55
+0.85%
GNMK
11.02
-0.32
-2.82%
HALO
11.445
-0.375
-3.173%
ILMN
126.18
-1.74
-1.36%
INNV
0.261
+0.003
+1.15892%
INO
7.06
-0.02
-0.28%
ISCO
1.2
+0.05
+4.35%
ISIS
0
0.00
0.00%
LGND
105.24
-1.27
-1.19%
LPTN
2.67
-0.046
-1.6972%
MBVX
4.07
-0.05
-1.21%
MEIP
1.55
-0.05
-3.13%
MNOV
7.64
+0.43
+5.96%
MRTX
5.075
-0.075
-1.456%
MSTX
0.083
-0.001
-0.9512%
NBIX
43.64
+0.03
+0.07%
NUVA
65.98
+0.12
+0.18%
ONCS
1.31
-0.05
-3.68%
ONVO
3.034
-0.066
-2.1419%
OREX
1.86
-0.04
-2.11%
OTIC
15.5
+0.35
+2.31%
QDEL
22.01
-0.01
-0.05%
RCPT
0
0.00
0.00%
RGLS
2.575
-0.275
-9.649%
RMD
59.06
-0.87
-1.45%
SCIE
0.002
+0.001
+35.7143%
SPHS
2.74
-0.06
-2.14%
SRNE
5.25
-0.05
-0.94%
TROV
2.45
-0.05
-2.00%
VICL
2.31
+0.01
+0.43%
ZGNX
13.1
+0.4
+3.15%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …